Yayın:
New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells

dc.contributor.authorYURTTAŞ, LEYLA
dc.contributor.authorAKALIN ÇİFTÇİ, GÜLŞEN
dc.contributor.orcid0000-0002-0957-6044
dc.contributor.orcid0000-0001-9535-2508
dc.date.accessioned2025-11-13T10:20:42Z
dc.date.issued2018-03-09
dc.identifier.doihttps://doi.org/10.2174/1871520618666180307142629
dc.identifier.endpage1130
dc.identifier.issn1871-5206
dc.identifier.issue8
dc.identifier.openalexW2791520647
dc.identifier.startpage1122
dc.identifier.urihttps://hdl.handle.net/11421/3864
dc.identifier.urihttps://doi.org/10.2174/1871520618666180307142629
dc.identifier.volume18
dc.language.isoen
dc.relation.ispartofAnti-Cancer Agents in Medicinal Chemistry
dc.rightsrestrictedAccess
dc.subjectCytotoxicity
dc.subjectQuinoline
dc.subjectChemistry
dc.subjectApoptosis
dc.subjectMoiety
dc.subjectStereochemistry
dc.subjectCytotoxic T cell
dc.subjectCisplatin
dc.subjectMTT assay
dc.subjectIC50
dc.subjectCell culture
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectOrganic chemistry
dc.subjectChemotherapy
dc.subject.sdg3
dc.titleNew Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5090129265
local.authorid.openalexA5059753642

Dosyalar

Koleksiyonlar